AWA
MDT icon

Authentikos Wealth Advisory’s Medtronic MDT Stock Holding History

Authentikos Wealth Advisory’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13
Closed -$1.02K – 365
2023
Q3 		$1.02K Buy
+13
New +$1.09K ﹤0.01% 515

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Authentikos Wealth Advisory's MDT Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of Medtronic (MDT) in Q4 2023, closing a stake of 13 shares — an estimated $1.02K sold.

Authentikos Wealth Advisory first reported a position in MDT in Q3 2023 and held it in 1 quarter. The position peaked at $1.02K in Q3 2023. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 13 Medtronic shares in Q4 2023, an estimated $1.02K.
  • Authentikos Wealth Advisory first reported a position in Medtronic in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's Medtronic position peaked at $1.02K in Q3 2023.
  • 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.